Russell C Dale Selected Research

Basal Ganglia Diseases (Basal Ganglia Disease)

1/2020	Magnetic resonance imaging pattern recognition in childhood bilateral basal ganglia disorders.
11/2012	Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders.
11/2012	Autoimmune basal ganglia disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Russell C Dale Research Topics

Disease

41	Encephalitis (Encephalitis, Rasmussen) 03/2022 - 01/2004
22	Demyelinating Diseases (Demyelinating Disease) 12/2021 - 02/2007
21	Seizures (Absence Seizure) 01/2021 - 06/2008
16	Inflammation (Inflammations) 03/2022 - 04/2009
16	Autoimmune Diseases of the Nervous System 03/2021 - 09/2010
15	Brain Diseases (Brain Disorder) 01/2020 - 06/2009
14	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 03/2022 - 10/2005
14	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 11/2021 - 05/2014
14	Neuromyelitis Optica (Devic's Disease) 01/2021 - 06/2009
13	Multiple Sclerosis 03/2022 - 02/2007
11	Epilepsy (Aura) 01/2020 - 06/2003
10	Movement Disorders (Movement Disorder) 01/2019 - 08/2010
10	Chorea (Rheumatic Chorea) 01/2016 - 03/2003
9	Neuroinflammatory Diseases 03/2022 - 07/2014
9	Optic Neuritis (Retrobulbar Neuritis) 01/2021 - 06/2009
9	Central Nervous System Diseases (CNS Diseases) 01/2017 - 06/2003
7	Transverse Myelitis (Necrotizing Myelitis) 01/2021 - 06/2009
6	Infections 01/2022 - 07/2014
6	Glioma (Gliomas) 10/2021 - 11/2011
6	Nervous System Diseases (Neurological Disorders) 10/2021 - 11/2011
6	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 03/2021 - 06/2003
6	Dystonia (Limb Dystonia) 12/2020 - 04/2009
5	Disease Progression 02/2022 - 12/2014
5	Mental Disorders (Mental Disorder) 01/2020 - 11/2012
4	Herpes Simplex Encephalitis (Herpes Encephalitis) 03/2022 - 04/2007
4	Autoimmune Diseases (Autoimmune Disease) 09/2021 - 06/2003
4	Parkinsonian Disorders (Parkinsonism) 12/2020 - 06/2011
4	Human Influenza (Influenza) 01/2019 - 01/2004
4	Status Epilepticus (Complex Partial Status Epilepticus) 01/2019 - 11/2011
4	Ataxia (Dyssynergia) 11/2017 - 06/2003
4	Psychotic Disorders (Schizoaffective Disorder) 09/2015 - 08/2011
3	Stroke (Strokes) 01/2022 - 01/2019
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 08/2010
3	Myasthenia Gravis 01/2021 - 03/2011
3	Basal Ganglia Diseases (Basal Ganglia Disease) 01/2020 - 11/2012
3	Myoclonic dystonia 01/2019 - 08/2011
3	Myelitis 01/2019 - 04/2009
3	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 01/2018 - 08/2010
3	Dyskinesias (Dyskinesia) 04/2017 - 01/2013
2	Bites and Stings (Sting) 01/2022 - 01/2022
2	Neurodevelopmental Disorders 01/2022 - 01/2022
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022 - 07/2007
2	Tourette Syndrome (Tourette's Syndrome) 01/2022 - 11/2012
2	Autism Spectrum Disorder 01/2022 - 12/2017
2	Teratoma (Teratoid Tumor) 01/2022 - 01/2017
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2022 - 10/2005
2	Cerebral Palsy (Spastic Diplegia) 01/2022 - 01/2020
2	chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature 01/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

42	AntibodiesIBA 10/2021 - 06/2003
37	AutoantibodiesIBA 01/2022 - 03/2003
29	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 11/2009
22	Myelin-Oligodendrocyte GlycoproteinIBA 03/2022 - 12/2009
16	Biomarkers (Surrogate Marker)IBA 03/2022 - 04/2009
15	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2011
10	Immunoglobulin G (IgG)IBA 01/2021 - 04/2007
9	CytokinesIBA 01/2020 - 01/2016
8	AntigensIBA 01/2021 - 12/2009
8	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021 - 06/2003
7	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 10/2016 - 11/2011
7	SteroidsIBA 06/2015 - 05/2004
6	NeopterinIBA 03/2022 - 04/2009
6	Leucine (L-Leucine)FDA Link 10/2021 - 11/2011
6	ChemokinesIBA 01/2019 - 01/2016
5	Biological ProductsIBA 10/2021 - 06/2009
5	Rituximab (Mabthera)FDA Link 10/2021 - 06/2011
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 08/2009
5	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018 - 01/2013
5	Oligoclonal BandsIBA 04/2015 - 11/2007
5	Dopamine (Intropin)FDA LinkGeneric 03/2015 - 11/2007
4	N-Methylaspartate (NMDA)IBA 03/2022 - 09/2010
4	InterferonsIBA 01/2022 - 01/2017
4	Interleukin-6 (Interleukin 6)IBA 01/2019 - 01/2016
4	EpitopesIBA 12/2016 - 10/2013
3	KynurenineIBA 03/2022 - 01/2021
3	Tryptophan (L-Tryptophan)FDA Link 03/2022 - 01/2021
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2022 - 01/2021
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2004
3	AcidsIBA 01/2021 - 01/2015
3	Pharmaceutical PreparationsIBA 01/2020 - 08/2010
3	Aminobutyrates (Aminobutyric Acid)IBA 01/2020 - 01/2015
3	Antiviral Agents (Antivirals)IBA 11/2017 - 10/2012
3	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2016 - 06/2013
3	Surface Antigens (Surface Antigen)IBA 01/2015 - 06/2011
2	Arginine (L-Arginine)FDA Link 03/2022 - 01/2021
2	Quinolinic AcidIBA 03/2022 - 01/2021
2	anthranilic acid (anthranilate)IBA 03/2022 - 01/2021
2	CitrullineIBA 03/2022 - 01/2021
2	Kynurenic Acid (Kynurenate)IBA 03/2022 - 01/2021
2	3-Hydroxyanthranilic AcidIBA 03/2022 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2022 - 12/2017
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022 - 01/2022
2	Immunoglobulin A (IgA)IBA 01/2022 - 03/2015
2	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 03/2015

Therapy/Procedure

22	Therapeutics 01/2022 - 06/2003
9	Immunotherapy 11/2021 - 11/2011
4	Plasma Exchange 08/2016 - 06/2011
3	Deep Brain Stimulation 12/2020 - 04/2017
2	Precision Medicine 01/2022 - 01/2019
2	Duration of Therapy 10/2021 - 01/2021
2	Plasmapheresis 01/2021 - 03/2011